Brodalumab in the Treatment of Various Forms of Psoriasis: A Narrative Review
Background: Brodalumab is a fully human monoclonal antibody that selectively targets the interleukin-17 receptor A (IL-17RA), blocking the activity of pro-inflammatory IL-17 cytokines. Purpose: The purpose of this study was to describe the efficacy and safety of brodalumab in treating various forms...
| Published in: | Journal of Dermatology and Dermatologic Surgery |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jdds.jdds_41_24 |